about the author

Josh Sullivan

josh@endpointsnews.com

author articles

Fu­ji­film boosts man­u­fac­tur­ing ca­pac­i­ty along­side R&D; Bax­ter In­ter­na­tion­al will in­vest $100M in Bio­Phar­ma So­lu­tions

4 years ago
Manufacturing

List Bio to join In­di­ana biotech com­mu­ni­ty with $125M CMO in­vest­ment, 210 new hires

4 years ago
Manufacturing

CPhI: The time of the CMO is up­on us as mas­sive in­dus­try growth dri­ves surge in out­sourc­ing ca­pac­i­ty

4 years ago
Outsourcing
Manufacturing

CPhI: Biotech's au­toma­tion boom is on­ly just be­gin­ning amid huge surge in de­mand due to Covid-19

4 years ago
Manufacturing

CPhI: In­dus­try ex­ecs ready to put a dif­fi­cult cou­ple years be­hind them as phar­ma con­fi­dence looks bull­ish

4 years ago
Manufacturing

CPhI: As Covid-19 re­stric­tions ease, an in­spec­tion back­log could have a big ef­fect on new drugs, gener­ics

4 years ago
Manufacturing

CPhI: Reg­u­la­to­ry changes have led to a CMO boom in Chi­na, but can that con­tin­ue?

4 years ago
Manufacturing

Ko­re­an reg­u­la­tors shut down Sam­sung Phar­ma man­u­fac­tur­ing af­ter find­ing ad­di­tives, false records

4 years ago
Manufacturing

BAR­DA, Emer­gent BioSo­lu­tions break off $600M Covid-19 vac­cine man­u­fac­tur­ing deal

4 years ago
Coronavirus
Manufacturing

Hic­cup in man­u­fac­tur­ing will cause Gen­Sight to re­peat the process for reti­nal gene ther­a­py; Den­dreon an­nounces ...

4 years ago
Manufacturing

Gen­Script drops a mod­est in­vest­ment in­to its sup­ply ca­pac­i­ty as busi­ness booms

4 years ago
Manufacturing

Catal­ent wraps up San Diego site build­out as it con­tin­ues to make waves with glob­al ac­qui­si­tions

4 years ago
Outsourcing
Manufacturing

Saudi­Vax and Mil­li­pore­Sig­ma team up to man­u­fac­ture do­mes­tic vac­cine for the Ara­bi­an penin­su­la

4 years ago
Coronavirus
Manufacturing

WuXi Bi­o­log­ics opens its newest fa­cil­i­ty in name­sake town amid glob­al ex­pan­sion ef­forts

4 years ago
Manufacturing

Lon­za en­ters the ex­o­some ther­a­py space with ac­qui­si­tion of still-new Co­di­ak site

4 years ago
Manufacturing

Platelet­Bio an­nounces $75.5M Se­ries B to ex­tend au­toim­mune cell ther­a­py

4 years ago
Deals
R&D

Covid-19 roundup: Eli Lil­ly with­draws mAbs from EMA re­view

4 years ago
Coronavirus

Cal­i­for­nia judge sides with drug­mak­ers in $50B opi­oid law­suit

4 years ago
Pharma

With the help of the NY gov­er­nor's of­fice, Strides Phar­ma ac­quires new man­u­fac­tur­ing site

4 years ago
Manufacturing

In key win, Ab­b­Vie lands FDA ap­proval for Al­ler­gan's blurred-vi­sion eye drop

4 years ago
FDA+

FDA clears Pfiz­er's Covid-19 vac­cine for chil­dren ages 5-11

4 years ago
FDA+
Coronavirus

Covid-19 roundup: Take­da preps roll­out of No­vavax shot for next year — re­port; G20 tar­gets 70% world vac­ci­na­tion ...

4 years ago
Coronavirus

A month af­ter Bio­con was hand­ed a Form 483, doc­u­ments re­veal lack­lus­ter con­di­tions

4 years ago
Manufacturing

Rid­ing Covid-19 high, As­pen plans new ad­di­tions at South African pro­duc­tion site

4 years ago
Manufacturing
First page Previous page 9101112131415 Next page Last page
A service from the Financial Times